Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
fasiglifam (TAK-875)
print preview
bookmark
share with colleague
General Information
Company
Takeda Pharmaceutical Co. Ltd.
Description
Free fatty acid receptor 1 (FFAR1; GPR40) agonist
Molecular Target
Free fatty acid receptor 1 (FFAR1) (GPR40)
Mechanism of Action
Latest Stage of Development
Phase III
Indication
Diabetes
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information